Faculty Directory
- Name
- Sok Bom KANG, M.D., Ph.D.(adjunct professor)
- Faculty Appointment
(title, department)
- Professor, Department of Cancer Control and Population Health, NCC-GCSP
- Area of Expertise
-
- E-mail
- sokbom@gmail.com
- Work Experience
- Educational Background
- Research Interests (Please place in paragraph form)
- International Collaboration
- Achievements
-
2022 SCI-E Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) study: INTERNATIONAL JOURNAL OF CANCER. Online:Published (7.316)
2022 SCI-E How Do Patients Value the Benefit of Minimally Invasive Surgery in Cancer Treatment?: VALUE IN HEALTH. 25(7):1212~1217 (5.101)
2021 SCI-E Clinical outcomes of BRCA1/2 pathogenic variants in ovarian cancer cluster region in patients with primary peritoneal, epithelial ovarian, and fallopian tube cancer: GYNECOLOGIC ONCOLOGY. Online:Published (5.482)
2021 SCI-E Predicting the risk of the distant recurrence of cervical cancer after concurrent chemoradiation: A validation study of the Korean Gynecologic Oncologic Group (KGOG)-1024 model: GYNECOLOGIC ONCOLOGY. 164(1):62~67 (5.482)
2021 SCI-E Is Korean society prepared for the financial burden of novel anticancer drugs? A survey of willingness to pay among National Health Insurance beneficiaries: SUPPORTIVE CARE IN CANCER. Online:Published (3.603)
2021 SCI-E How to manage synchronous endometrial and ovarian cancer patients?: BMC CANCER. 21(1):489~ (4.43)
2021 SCI-E The knowledge and attitude of patients diafnosed with epithelial ovarian cancer towards genetic testing: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 18(5):2312~ (3.39)
2020 Glycolytic phenotypes in an evaluation of ovarian carcinoma based on carcinogenesis and BRCA mutation: . :~ ()
2020 SCI-E Prevalence of pathogenic variants in actionable genes in advanced ovarian cancer: a next-generation sequencing analysis of a nationwide registry study.: EUROPEAN JOURNAL OF CANCER. 141:185~192 (7.275)
2020 SCI-E Glycolytic phenotypes in an evaluation of ovarian carcinoma based on carcinogenesis and BRCA mutation.: EUROPEAN JOURNAL OF RADIOLOGY. 133:109391~ (2.687)
2020 SCI-E Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: YONSEI MEDICAL JOURNAL. 61(11):935~941 (1.914)
2020 SCI-E The survival effect of ovary preservation in early stage endometrial cancer: a single institution retrospective analysis: JOURNAL OF OVARIAN RESEARCH. 13(1):97~ (2.989)
2020 SCI-E Uptake of Family-specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2mutation: CANCER RESEARCH AND TREATMENT. Online:Published (3.761)
2020 SCI-E The impact of depressive symptoms on health value in patients with gynecologic cancer: A comparison with physical symptoms and performance status: GYNECOLOGIC ONCOLOGY. 157(3):733~739 (4.623)
2020 SCI-E Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R): EUROPEAN JOURNAL OF CANCER. Online:Published (7.275)
2020 SCI-E Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 30(6):764~771 (2.095)
2019 Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study: Current Problems in Cancer. : (3.698)
2019 SCI-E Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. Online:Published (2.183)
2019 SCI Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041): GYNECOLOGIC ONCOLOGY. 152(1):61~67 (4.54)
2018 SCI Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae: Journal of cancer research and clinical oncology. 144(5):845~854 (3.282)
2017 SCI-E Role of preoperative magnetic resonance imaging and histologic assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study: Oncotarget. 8(62):106009~106016 (5.168)
2017 SCI-E Comparing prediction models forlymph node metastasis risk inendometrial cancer: the winner maynot take it all: journal of gynecologic oncology. 28:e92~e92 (3.14)
2017 SCI-E Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers: BMC cancer. 17:407~407 (3.288)
2017 SCI-E Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer: Journal of Gynecologic Oncology. 28(4):e48~e48 (3.14)
2017 SCI-E Do we need a better marker for successful ovarian cancer surgery?: Journal of Gynecologic Oncology. 28(1):e21~e21 (3.14)
2016 SCI Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study: Cancer. 123(2):263~272 (5.649)
2016 SCI Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial: Radiotherapy and Oncology. 120(3):383~389 (4.817)
2016 SCI-E Health Behaviors and Associated Sociodemographic Factors in Cervical Cancer Survivors Compared with Matched Non-Cancer Controls.: PLoS One. 11(8):e0160682~e0160682 (3.057)
2016 SCI Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer: International Journal of Gynecological Cancer. 26(4):737~742 (2.116)
2016 SCI-E Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea: BMC Cancer. 16:5~5 (3.265)
2015 SCI-E Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer: Cancer research and treatment. 48(2):641~649 (3.318)
2015 SCI Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer: Annals of surgical oncology. 23(1):186~195 (3.93)
2015 SCI Comparison of Lower Extremity Edema in Locally Advanced Cervical Cancer: Pretreatment Laparoscopic Surgical Staging with Tailored Radiotherapy Versus Primary Radiotherapy.: Annals of surgical oncology. 23(1):203~210 (3.93)
2015 SCI Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.: Journal of Cancer Research and Clinical Oncology. 142(1):333~340 (3.081)
2015 SCI Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection: European journal of obstetrics, gynecology, and reproductive biology. 192:31~36 (1.695)
2015 SCI-E Multi-dimensional TOF-SIMS analysis for effective profiling of disease-related ions from the tissue surface.: Scientific reports.. 5:11077~11085 (5.578)
2015 SCI-E Incidental cholecystectomy in patients with asymptomatic gallstones undergoing surgery for colorectal cancer.: Digestive surgery. 32(3):183~189 (2.162)
2015 SCI-E Ligation of uterine vessels in total laparoscopic hysterectomy using Hem-o-lok clips.: Taiwanese journal of obstetrics & gynecology. 54(1):8~12 (0.988)
2015 SCI-E Survival outcome in endometrial cancer patients according to hereditary predisposition: Taiwanese journal of obstetrics & gynecology. 54(1):24~28 (0.988)
2015 SCI Benefit of Negative Pressure Drain Within Surgical Wound After Cytoreductive Surgery for Ovarian Cancer: International jouranl of gynecological cancer. 25(1):145~151 (1.958)
2014 SCI The cost-effectiveness of selective lymphadenectomy based on a preoperative prediction model in patients with endometrial cancer: Insights from the US and Korean healthcare systems: Gynecologic Oncology. 135(3):518~524 (3.687)
2014 SCI Low Expression of miR-449 in Gynecologic Clear Cell Carcinoma: International journal of gynecological cancer. 24(9):1558~1563 (1.949)
2014 SCI Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary: International journal of gynecological cancer. 24(9-3):s20~s25 (1.949)
2014 기타 The antihypertension drug doxazosin suppresses JAK/STATs phosphorylation and enhances the effects of IFN-α/γ-induced apoptosis: Genes and Cancer. 5 (11-12):470~479 (0)
2014 SCI Lymph Node Status Did Not Significantly Improve the Predictability of Survival in Patients With Clinically Early-Stage Endometrial Cancer: International journal of gynecological cancer. 24(8):1449~1454 (1.949)
2014 SCI-E Completeness of pedigree and family cancer history for ovarian cancer patients: Journal of gynecologic oncology. 25(4):342~348 (1.6)
2014 SCI-E Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts: Oncotarget. 5(13):4929~4934 (6.627)
2014 SCI-E Major clinical research advances in gynecologic cancer in 2013: Journal of gynecologic oncology. 25(3):236~248 (1.6)
2014 SCI Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors: Gynecologic Oncology. 133(1):111~116 (3.687)
2014 SCI-E Lower extremity edema in patients with early ovarian cancer: Journal of ovarian research. 7(1):28~28 (2.03)
2014 SCI A Web-Based Nomogram Predicting Para-aortic Nodal Metastasis in Incompletely Staged Patients With Endometrial Cancer: A Korean Multicenter Study: International journal of gynecological cancer. 24(3):513~519 (1.949)
2014 SCI Application of a subcutaneous negative pressure drain without subcutaneous suture: impact on wound healing in gynecologic surgery: European journal of obstetrics & gynecology and reproductive biology. 173:94~100 (1.627)
2014 SCI-E Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer: Journal Of Obstetrics & Gynaecology Research. 40(2):317~21 (0.931)
2014 SCI-E Proposal of a concept and design of a randomized phase III trial investigating the survival effect of para-aortic lymphadenectomy in endometrial cancer: The journal of obstetrics and gynaecology research. 40(2):312~316 (0.931)
2014 SCI-E Risk assessment of lymph node metastasis before surgery in endometrial cancer: do we need a clinical trial for low-risk patients?: The journal of obstetrics and gynaecology research. 40(2):322~326 (0.931)
2013 Use of complex surgical procedures, patterns of tumor spread, and CA-125 predicts a risk of incomplete cytoreduction: a Korean Gynecologic Oncology Group study (KGOG-3022): Gynecologic oncology. 131(2):336~340 (3.929)
2013 SCI Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study: Gynecologic Oncology. 131(2):294~298 (3.929)
2013 SCI-E Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.: Journal of Gynecologic Oncology. 24(4):298~302 (1.73)
2013 기타 Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model.: ClinicoEconomics and outcomes research. 5:297~307 (0)
2013 SCI Discrepancy Between Preoperative Imaging and Surgical Findings in Patients With Advanced Ovarian Cancer: A Study of Initial False-Negative Lesions: Journal of Computer Assisted Tomography. 37(4):568~571 (1.582)
2013 SCI The size of the metastatic lymph node is an independent prognostic factor for the patients with cervical cancer treated by definitive radiotherapy: Radiotherapy and Oncology. 1081(1):168~173 (4.52)
2013 SCI-E Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition: Journal of Gynecologic Oncology. 24(2):186~203 (1.73)
2013 SCI A low-risk group for lymph node metastasis is accurately identified by Korean gynecologic oncology group criteria in two Japanese cohorts with endometrial cancer: Gynecologic oncology. 129(1):33~37 (3.929)
2013 SCI-E High Control Rate for Lymph Nodes in Cervical Cancer Treated with High-dose Radiotherapy using Helical Tomotherapy: Technology in Cancer Research and Treatment. 12(1):45~51 (1.943)
2013 SCI-E Coexisting carcinoma in endometrial hyperplasia: does more risk factor mean better discrimination?: Journal of Gynecologic Oncology. 24(1):1~2 (1.73)
2013 SCI-E Brain metastasis in patients with uterine cervical cancer: Journal of Obstetrics and Gynaecology Research. 39(1):287~291 (0.841)
2012 SCI-E Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.: Archives of gynecology and obstetrics.. 286(6):1529~1535 (1.277)
2012 SCI-E Urologic complications of laparoscopic radical hysterectomy and lymphadenectomy: International urogynecology journal. 23(11):1605~1611 (1.832)
2012 SCI Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway: Microvascular Research. 84(3):227~234 (2.828)
2012 SCI-E Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea: Journal of Gynecology Oncology. 23(4):242~250 (1.489)
2012 SCI Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.: Apoptosis. 17(9):989~997 (4.788)
2012 SCI Risk Assessment Tool for Distant Recurrence After Platinum-Based Concurrent Chemoradiation in Patients With Locally Advanced Cervical Cancer: A Korean Gynecologic Oncology Group Study.: Journal of Clinical Oncology. 30(19):2369~2374 (18.372)
2012 기타 Intraoperative image-guided surgery for ovarian cancer: Quantitative imaging in medicine and surgery. 3:114~117 (0)
2012 SCI Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy.: Fertility and sterility.. 97(6):1387~1393 (3.775)
2012 SCI Serum HE4 Level is an Independent Prognostic Factor in Epithelial Ovarian Cancer: Annals of Surgical Oncology. 19(5):1707~1712 (4.166)
2012 SCI Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study: Journal of Clinical Oncology. 30(12):1329~1334 (18.372)
2012 SCI-E Performance of Papanicolaou Testing and Detection of Cervical Carcinoma In Situ in Participants of Organized Cervical Cancer Screening in South Korea: PLoS ONE. 7(4):e35469~e35469 (4.092)
2012 SCI Correlation Between Body Mass Index and Prevalence of Hereditary Nonpolyposis Colorectal Cancer in Korean Patients With Endometrial Cancer: International Journal of Gynecological Cancer. 22(2):267~272 (1.646)
2012 SCI Management of the Elderly Patient With Gynecologic Cancer: Report of the 2011 Workshop in Geriatric Gynecologic Oncology.: International Journal of Gynecological Cancer. 22(1):161~169 (1.646)
2011 SCI-E Outcomes and toxicities for the treatment of stage IVB cervical cancer: Archives of gynecology and obstetrics. 285(6):1685~1693 (1.277)
2011 SCI Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer.: Anticancer drugs. Online:Published (2.376)
2011 SCI Alteration in lipid and protein profiles of ovarian cancer: similarity to breast cancer.: International Journal of Gynecological Cancer. 21(9):1566~1572 (1.558)
2011 SCI Is Neo-adjuvant Chemotherapy a "Waiver" of Extensive Upper Abdominal Surgery in Advanced Epithelial Ovarian Cancer?: Annals of Surgical Oncology. 18(13):3824~3827 (4.182)
2011 SCI Sentinel lymph node biopsy in endometrial cancer: Meta-analysis of 26 studies.: Gynecologic oncology. 123(3):522~527 (3.76)
2011 SCI Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer: International Journal of Cancer. 129(4):896~902 (4.926)
2011 SCI-E Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 41(5):624~629 (1.856)
2011 SCI Cyclooxygenase-2 is an independent predictor of poor prognosis in uterine leiomyosarcomas: Int J Gynecol Cancer. 21:668~672 (1.558)
2011 SCI Extended Cytoreduction of Tumor at the Porta Hepatis by an Interdisciplinary Team Approach in Patients with Epithelial Ovarian Cancer: Gynecologic Oncology. 121(2):253~257 (3.76)
2011 SCI-E Cervical adenocarcinoma in situ with negative conization margin: negligible or not?: Journal of gynecologic oncology. 22(1):1~2 (0)
2011 SCI Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels.: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 72(1):50~54 (1.031)
2011 SCI Pelvic Lymph Node Status Assessed by 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Low-Risk Group for Distant Recurrence in Locally Advanced Cervical Cancer: A Prospective Study.: International journal of radiation oncology, biology, physics. 79(3):788~793 (4.503)
2011 SCI-E Region-based Diagnostic Performance of Multi-detector CT for Detecting Peritoneal Seeding in Ovarian Cancer Patients: Archives of Gynecology and Obstetrics. 283(2):353~360 (1.072)
2011 SCI Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53: FEBS Letters. 585:29~35 (3.601)
2011 SCI A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway: Gynecologic Oncology. 120(1):121~127 (3.76)
2011 SCI Interaction between preoperative CA-125 level and survival benefit of neoadjuvant chemotherapy in advanced epithelial ovarian cancer: Gynecologic Oncology. 120(1):18~22 (3.76)
2010 SCI-E Epidemiological characteristics of ovarian cancer in Korea: Journal of Gynecologic Oncology. 21:241~247 ()
2010 SCI Identification of a patient group at low risk for parametrial invasion in early-stage cervical cancer.: Gynecologic oncology. 119(3):426~430 (3.733)
2010 SCI-E Hereditary Non-polyposis Colorectal Cancer/Lynch Syndrome in Korean Patients with Endometrial Cancer: Japanese Journal of Clinical Oncology. 40(12):1121~1127 (1.498)
2010 SCI Preoperative prediction model of lymph node metastasis in endometrial cancer.: International Journal of Gynecological Cancer. 20(8):1350~1355 (2.179)
2010 SCI Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer: Gynecologic Oncology. 118:58~63 (3.733)
2010 SCI Feasibility and Safety of Extensive Upper Abdominal Surgery in Elderly Patients with Advanced Epithelial Ovarian Cancer: Journal of Korean Medical Science. 25(7):1034~1040 (0.838)
2010 SCI Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer: Onkologies. 33(6):324~330 (1.234)
2010 SCI-E Lower urinary tract injuries diagnosed after hysterectomy: Seven-year experience at a cancer hospital: The Journal Of Obstetrics and Gynaecology Research. 36:318~325 (0.777)
2010 SCI Diagnostic Value of 18F-FDG PET for Evaluation of Paraaortic Nodal Metastasis in Patients with Cervical Carcinoma: A Metaanalysis.: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 51(3):360~367 (6.424)
2010 SCI-E Comparison of the efficacy between topotecan- and belotecan-, a new camptothecin analog, based chemotherapies for recurrent epithelial ovarian cancer: a single institutional experience: The journal of obstetrics and gynaecology research. 36(1):86~93 (0.777)
2010 SCI Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer: European Radiology. 20:100~107 (3.589)
2010 SCI Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: A meta-analysis.: Journal of Surgical Oncology. 101(1):13~17 (2.502)
2009 SCI-E The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer: European Journal of Radiology. 75(2):230~235 (2.645)
2009 SCI-E Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma: Archives of Gynecology and Obstetrics. 281(2):329~334 (0.912)
2009 SCI BRCA1 and BRCA2 Germline Mutations in Korean Ovarian Cancer Patients: Journal of Cancer Research and Clinical Oncology. 153(11):1593~1599 (2.217)
2009 SCI Embryonic natural orifice transumbilical endoscopic surgery (E-NOTES) for adnexal tumors: Surgical Endoscopy. 23(11):2445~2449 (3.231)
2009 SCI Natural history of persistent high-risk human papillomavirus infections in Korean women: Gynecologic Oncology. 115(1):75~80 (2.919)
2009 SCI Nadir CA-125 level is an independent prognostic factor in advanced epithelial ovarian cancer: Journal of Surgical Oncology. 100(3):244~247 (2.478)
2009 SCI Total colectomy as part of primary cytoreductive surgery in advanced mullerian cancer: Gynecologic Oncology. 114(2):183~187 (2.919)
2009 SCI Does Neoadjuvant Chemotherapy Increase Optimal Cytoreduction Rate in Advanced Ovarian Cancer? Meta-Analysis of 21 Studies: Annals of Surgical Oncology. 16(8):2315~2320 (3.898)
2009 SCI-E Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis: Gynecological Endocrinology. 25(7):435~440 (1.359)
2009 SCI-E Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer: Journal of Gynecologic Oncology. 20(2):101~106 ()
2009 SCI-E Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia: Journal of Gynecologic Oncology. 20(2):86~90 (0)
2009 SCI Hyperthermic Intraperitoneal Chemotherapy Following Extensive Cytoreductive Surgery in Patients with Primary Advanced Epithelial Ovarian Cancer: Interim Analysis of a Phase II Study: Annals of Surgical Oncology. 16(4):993~1000 (3.898)
2009 SCI Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life Questionnaire Cervical Cancer Module: Oncology. 76(3):190~198 (1.336)
2008 SCI The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer.: Gynecologic Oncology. 112(1):28~34 (2.614)
2008 SCI Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety: International Journal of Gynecological Cancer. Online:Published (1.425)
2008 SCI Insulin-like growth factor binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis: Carcinogenesis. 29:2106~2111 (5.406)
2008 SCI Occult para-aortic lymph node metastasis after negative positron emission tomography/computed tomography scan: Journal of Clinical Oncology. 26(31):5140~5140 (15.5)
2008 SCI-E Unusual 2-[18F]-fluoro-2-deoxy-D: -glucose accumulation induced by postoperative intestinocutaneous fistula in the patient with uterine cervical cancer and SLE.: Archives of Gynecology and Obstetrics. Online:Published (0.666)
2008 SCI Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects: International Journal of Gynecological Cancer. 18:1013~1019 (1.425)
2008 SCI The validity of tumour diameter assessed by magnetic resonance imaging and gross specimen with regard to tumour volume in cervical cancer patients: European Journal of Cancer. 44:1524~1528 (4.454)
2008 SCI The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization: Gynecologic Oncology. 108:549~554 (2.614)
2008 SCI Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma.: International Journal of Gynecological Cancer(상위20#이내 학술지 아님). Online:Published (1.425)
2008 SCI FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer: Cancer Genetics and Cytogenetics. 180:1~5 (1.559)
2007 SCI Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer: International Journal of Gynecological Cancer. 17:492~496 (1.428)
2007 SCI Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer: JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH. 33(3):236~41 (0.83)
2007 SCI Port-site and liver metastases after laparoscopic pelvic and para-aortic lymph node dissection for surgical staging of locally advanced cervical cancer cancer: International Journal of Gynecological Cancer. 18:176~180 (1.425)
2007 기타 The Effect of Tibolone on Bone Density in Women with Early Menopause Resulting from Cancer Treatment: Journal of the Korean society of osteoporosis. 5:72~77 (0)
2007 SCI The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy: International Journal of Gynecologic Cancer. 17:872~878 (1.469)
2007 SCI Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.: Gynecol Oncol.. Online:Published (2.319)
2007 SCI Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma: Gynecologic Oncology(상위20#이내 학술지 아님). 105:662~666 (2.319)
2007 SCI The C19007T Polymorphism of ERCC1 and Its Correlation with the Risk of Epithelial Ovarian and Endometrial Cancer in Korean Women. A Case Control Study.: Gynecologic and obstetric investigation. 64:84~88 (0.874)
2007 SCI Interleukin-1 beta-511 polymorphism and risk of cervical cancer: Journal of Korean Medical Science. 22:110~113 (0.824)
2006 SCI The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns: Gynecologic Oncology. 103:977~984 (2.251)
2006 SCI CT findings of clear cell carcinoma of the ovary: Journal of Computer Assisted Tomography. 30:875~879 (1.369)
2006 SCI MRI for pretreatment lymph node staging in uterine cervical cancer: American Journal of Roentgenology. 187:538~543 (2.209)
2006 SCI Contrast-enhanced CT for differentiation of ovarian metastasis from gastrointestinal tract cancer: stomach cancer versus colon cancer.: American journal of roentgenology. 187:741~745 (2.209)
2006 SCI RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma: International Journal of Cancer. 119:1316~1321 (4.7)
2006 SCI Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer: Experimental and Molecular Medicine. 38:320~324 (2.296)
2006 SCI Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix: Cancer Letters. 239:198~204 (3.277)
2006 SCI Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma: International journal of cancer. 118:2168~2171 (4.7)
2005 SCI Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer: Cancer Letter. 217:11~6 (3.398)
2005 SCI Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women: International Journal of Gynecological Cancer. 15:107~12 (1.548)
2005 SCI Feasibility of radical surgery in the management of elderly patients with uterine cervical cancer in Korea: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 59:165~70 (1.15)
2005 SCI Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women: Cancer Letter. 217:191~6 (3.398)
2005 SCI Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer: Gynecologic Oncology. 96:173~80 (2.614)
2005 SCI Cyclin D1 polymorphism and the risk of endometrial cancer: Gynecologic Oncology. 97:431~5 (2.61)
2004 SCI Cyclooxygenase-2 and p53 expressions in endometrial cancer: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 13:1538~42 (4.642)
